Lakefront Biotherapeutics NV (GLPGF) Q3 2024 Earnings

Aug 1Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-2.13
-0.56
1.01
2.59

Details

Expected EPS
-0.07332244848
Actual EPS
0.11265183264
Surprise EPS
0.19
Surprise Percent
+253.64%

Description

⁨Lakefront Biotherapeutics NV⁩ (⁦GLPGF⁩) has reported earnings of ⁦0.11265183264⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts